Phillip A. Sharp Net Worth & Insider Trades

Phillip A. Sharp - Director, Alnylam Pharmaceuticals, Inc

As of July 2, 2019

What is Phillip A. Sharp's Net Worth?

The current estimated net worth of Alnylam Pharmaceuticals, Inc's Director, Phillip A. Sharp, is estimated to be about $341.15M . Phillip A. Sharp owns about 266,899 units of Alnylam Pharmaceuticals, Inc common stock. In the last 15 years at Alnylam Pharmaceuticals, Inc, Phillip A. Sharp has sold an estimated value of $20.25M worth.

What is Phillip A. Sharp's Past Insider Trading?

Phillip A. Sharp's largest purchase order was 131,890 units , worth over $847.8K on October 15, 2014. Phillip A. Sharp's largest sale order was 131,890 units , worth over $9.35M on October 15, 2014. In total, Phillip A. Sharp has made about 28 transactions over 15 years of their time at Alnylam Pharmaceuticals, Inc. Phillip A. Sharp usually trades in June, with the busiest year in 2017. The most recent transaction was a sale order of 15,000 units , worth over $1.32M on April 17, 2019.

Phillip A Sharp

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Phillip A. Sharp's' Mailing Address?

  • Mailing address is Biogen Inc Legal Department 14 Cambridge Center Cambridge MA 02142 MA

What are Alnylam Pharmaceuticals, Inc's Past Insider Trades?

Alnylam Pharmaceuticals, Inc's most recent insider trade came on March 7, 2023 by Pushkal Garg who sold 18,072 units worth $3.61M . In the last 19 years, insiders at Alnylam Pharmaceuticals, Inc have sold an estimated value of $520.88M and bought an estimated value of $251.63M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are John Maraganore, Chief Executive Officer,  Akshay Vaishnaw, President,  and Barry E Greene, President .

POLARIS INDUSTRIES INC/MN Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...